EDN1 and lung carcinoma: The same authors demonstrated that the upregulation of ET-1 and its receptors in the lung cancer niche is crucial in mediating the effects of fibrocytes, while bosentan impaired the in vitro and in vivo effects, associated with decreased Col1 expression [30].